Drug Stocks: Alkermes Plc (NASDAQ:ALKS), Petmed Express Inc (NASDAQ:PETS), Columbia Laboratories (NASDAQ:CBRX), Acura Pharmaceuticals (NASDAQ:ACUR)

Alkermes Plc (NASDAQ:ALKS) COO Gordon G. Pugh unloaded 16,000 shares of the stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $46.49, for a total transaction of $743,840.00. Following the completion of the transaction, the chief operating officer now directly owns 55,777 shares of the company’s stock, valued at approximately $2,593,073. Alkermes Plc (NASDAQ:ALKS) net profit margin is -1.20% and weekly performance is 1.74%. On last trading day company shares ended up $50.97. Analysts mean target price for the company is $50.92. Alkermes Plc (NASDAQ:ALKS) distance from 50-day simple moving average is 8.37%.

Petmed Express Inc (NASDAQ:PETS) got a Zacks Rank #2 (Buy). Petmed Express Inc (NASDAQ:PETS) shares advanced 2.00% in last trading session and ended the day on $13.78. PETS Gross Margin is 33.20% and its return on assets is 29.00%. Petmed Express Inc (NASDAQ:PETS) quarterly performance is 4.47%.

Columbia Laboratories, Inc. (“Columbia” or “the Company”), a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, announced that it has been added to the preliminary list for the Russell Microcap Index, to be finalized on June 27, 2014. Columbia Laboratories Inc. (NASDAQ:CBRX) shares moved down -2.09% in last trading session and was closed at $6.55, while trading in range of $6.49-$6.76. Columbia Laboratories Inc. (NASDAQ:CBRX) year to date performance is -0.91%.

——Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) ended the last trading day at $1.10. Company weekly volatility is calculated as 4.90% and price to cash ratio as 2.39. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) showed a positive weekly performance of 1.85%.